I agree. I’m simply referring to the reason why they’re diluting. <br /> <br /> Debt conversions? <br /> Raising capital for clinical trials? <br /> Buy-out? <br /> <br /> The market is certainly swallowing those shares up, we’ve traded that in the last two sessions. <br /> <br /> What we don’t want to see is dilution for dilution sake. Dilution isn’t some scary word if the capital raised is actually utilized. If not, then it was simply to line insiders and debt holders pockets.